ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Annexon, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$4.01+0.60 (+17.60%)

Close on Oct 19, 2026

Market cap: $806.02M
P/E (TTM): –
Dividend yield: 0.00%

Annexon, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31
Cash & Equivalents	199	175	162	139	133	98	51	81	158	153	226	134	115	145	141	212	106	114	76	70	101	208	269	371	125	33	44	54	31	–	44
Short-Term Investments	9.97	50	76	49	95	167	263	261	211	113	35	32	79	84	103	59	73	94	168	203	203	120	83	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	209	225	238	189	227	264	312	340	369	265	260	165	193	228	243	270	178	207	243	271	302	327	351	371	125	33	44	54	31	–	44
Prepaid Expenses & Other	3.51	3.24	3.85	4.10	3.60	4.47	4.44	4.18	5.27	5.79	4.14	3.90	4.62	4.37	5.44	5.26	3.78	4.60	4.98	4.13	2.01	3.87	2.81	2.89	0.91	–	1.48	–	–	–	–
Other Current Assets	–	–	–	–	–	–	–	–	–	0.02	0.06	0.01	0.17	0.17	0.20	0.06	0.04	0.13	0.46	0.23	–	0.04	0.00	0.00	–	–	0.08	–	–	–	–
Total Current Assets	213	228	242	193	231	268	316	344	374	271	264	169	198	233	248	275	181	211	248	275	304	331	354	374	126	–	45	–	–	–	–
Property, Plant & Equipment	9.68	10	11	11	12	12	13	13	14	14	15	15	16	16	17	17	17	18	18	12	5.13	1.43	1.94	2.04	2.05	–	2.14	–	–	–	–
Gross Property, Plant & Equipment	20	20	20	20	20	20	20	20	20	20	20	20	20	20	20	19	19	19	19	16	–	–	3.91	–	–	–	3.44	–	–	–	–
Accumulated Depreciation	-10	-9.88	-9.35	-8.80	-8.26	-7.72	-7.18	-6.64	-6.10	-5.57	-5.03	-4.49	-3.96	-3.42	-2.88	-2.35	-1.83	-1.30	-0.79	-3.61	-3.05	-2.51	-1.97	-1.70	-1.57	–	-1.30	–	–	–	–
Operating Lease Right-of-Use Assets	14	15	15	16	16	16	17	17	17	18	18	18	19	19	19	20	20	20	20	21	21	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	8.27	8.72	8.55	8.55	5.30	5.30	3.24	3.23	–	0.36	–	–	–	0.01	–	0.20	1.02	0.24	–	0.59	–	–	–	–	3.37	–	2.35	–	–	–	–
Total Assets	246	263	278	229	265	303	350	379	406	304	298	204	233	269	285	313	221	251	287	310	332	333	356	376	131	–	50	–	–	–	–
Accounts Payable	16	18	15	18	12	10	10	6.75	4.13	3.97	5.49	4.81	7.16	10	7.42	6.92	10	9.38	11	4.80	4.18	4.52	3.73	3.95	3.06	–	2.37	–	–	–	–
Accrued Expenses	–	–	–	–	–	–	–	–	11	6.86	10	10	8.95	11	13	11	8.06	6.21	9.25	7.06	5.85	5.78	6.50	4.65	9.22	–	2.19	–	–	–	–
Current Portion of Leases	3.13	3.02	2.91	2.82	2.72	2.62	2.52	2.44	2.35	2.25	2.17	1.70	1.62	1.53	1.32	1.81	1.73	1.28	1.20	0.06	0.25	–	–	–	–	–	–	–	–	–	–
Other Current Liabilities	–	–	–	–	–	–	–	–	0.02	0.05	0.04	0.17	0.16	0.38	0.18	0.17	0.16	0.19	0.14	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	38	36	43	44	41	34	31	20	17	13	18	17	18	23	22	20	20	17	22	12	10	11	11	8.99	13	–	4.93	–	–	–	–
Long-Term Leases	22	22	23	24	25	26	26	27	28	29	29	30	30	31	32	32	32	33	33	34	26	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	25	25	26	27	28	28	29	30	30	31	31	32	32	33	33	34	34	34	35	34	26	–	–	–	–	–	–	–	–	–	–
Total Liabilities	60	58	66	68	66	59	57	47	45	42	47	47	48	54	54	52	53	50	55	46	36	12	12	10	14	–	6.37	–	–	–	–
Common Stock	0.18	0.16	0.15	0.12	0.11	0.11	0.11	0.11	0.11	0.09	0.08	0.05	0.05	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.00	–	0.00	–	–	–	–
Additional Paid-In Capital	1,203	1,166	1,129	1,031	1,013	1,009	1,004	993	988	860	823	702	697	692	670	665	537	533	528	523	519	514	510	508	9.37	–	2.20	–	–	–	–
Retained Earnings	-1,017	-962	-917	-869	-814	-765	-711	-662	-627	-598	-572	-545	-512	-477	-438	-404	-369	-332	-296	-259	-223	-192	-166	-143	-127	–	-103	–	–	–	–
Comprehensive Income & Other	-0.08	-0.08	-0.03	-0.08	-0.09	-0.09	0.01	0.08	-0.09	-0.10	-0.05	-0.12	-0.17	-0.22	-0.37	-0.41	-0.44	-0.37	-0.18	-0.08	-0.07	-0.10	-0.08	-0.08	-0.08	–	-0.08	–	–	–	–
Shareholders' Equity	186	205	212	161	199	244	293	332	361	262	251	157	185	215	231	261	168	201	232	264	295	321	344	365	-118	-112	-100	-92	-82	-73	-64
Total Equity	186	205	212	161	199	244	293	332	361	262	251	157	185	215	231	261	168	201	232	264	295	321	344	365	-118	-112	-100	-92	-82	-73	-64
Total Liabilities & Equity	246	263	278	229	265	303	350	379	406	304	298	204	233	269	285	313	221	251	287	310	332	333	356	376	131	–	50	–	–	–	–
Shares Outstanding(shares)	–	–	149	–	–	–	109	–	–	–	78	–	–	–	48	–	–	–	39	–	–	–	38	38	0.43	–	0.43	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -81.9%

Financial strength

Current ratio: 5.53
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 517.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 4.33
Dividend yield: 0.00%